(See Glen Report-Vol.9, No.1, 1996,page 8.) Deprotection: No changes needed from standard method recommended by synthesizer manufacturer. Storage: Storage: Refrigerated storage, maximum of 2-8°C, dry Stability in Solution: 3-5days
QUESTION: What is a possible alterternative oxidizing solution to I2 ?RESPONSE:In situations where you want to avoid the use of iodine containing oxidizing solutions, such as when using 7-deaza-dG, or when you want to use a non aqueous oxidizing solution t-butyl hydroperoxide (TBHP) has been shown to work both for DNA (1) and RNA (2).
The pyrrolocytosine RX-P873, a new broad-spectrum antibiotic in preclinical development, inhibits protein synthesis at the translation step. The aims of this work were to study RX-P873’s ability to accumulate in eukaryotic cells, together with its activ-ity against extracellular and intracellular forms of infection by Staphylococcus aureus and Pseudomonas aeruginosa, using a pharmacodynamic approach allowing the determination of maximal relative efficacies (Emax values) and bacteriostatic concen-trations (Cs values) on the basis of Hill equations of the concentration-response curves. RX-P873’s apparent concentration in human THP-1 monocytes was about 6-fold higher than the extracellular one. In broth, MICs ranged from 0.125 to 0.5 mg/liter (S. aureus) and 2 to 8 mg/liter (P. aeruginosa), with no significant shift in these values against strains resistant to currently used antibiotics being noted. In concentration-dependent experiments, the pharmacodynamic profile of RX-P873 was not influenced by the resistance phenotype of the strains. Emax values (expressed as the decrease in the number of CFU from that in the initial inoculum) against S. aureus and P. aeruginosa reached more than 4 log units and 5 log units in broth, respectively, and 0.7 log unit and 2.7 log units in infected THP-1 cells, respectively, after 24 h. Cs values remained close to the MIC in all cases, making RX-P873 more potent than antibiotics to which the strains were resistant (moxifloxacin, vancomycin, and daptomycin for S. aureus; ciprofloxacin and ceftazidime for P. aeruginosa). Kill curves in broth showed that RX-P873 was more rapidly bacteri-cidal against P. aeruginosa than against S. aureus. Taken together, these data suggest that RX-P873 may constitute a useful alter-native for infections involving intracellular bacteria, especially Gram-negative species.
On 15 June 2016 Sound On Sound launched our new website